Nexalin Technology (NXL) Share-based Compensation Growth (3y) (2024 - 2025)
Nexalin Technology (NXL) Share-based Compensation Growth (3y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | - |
| 10 | Nexalin Technology | 9.12 Mn | 6.41 Mn | 13,133.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 80.45% |
| Jun 30, 2025 | 49.39% |
| Mar 31, 2025 | 86.93% |
| Dec 31, 2024 | 134.71% |
| Sep 30, 2024 | 0.98% |